Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Diseases | 5 | 2022 | 388 | 0.890 |
Why?
|
Colitis | 6 | 2022 | 173 | 0.840 |
Why?
|
Cholestasis | 3 | 2022 | 158 | 0.800 |
Why?
|
Liver | 4 | 2025 | 1850 | 0.520 |
Why?
|
Colitis, Ulcerative | 4 | 2022 | 218 | 0.500 |
Why?
|
Liver Transplantation | 5 | 2025 | 1118 | 0.460 |
Why?
|
Argininosuccinate Lyase | 3 | 2021 | 63 | 0.440 |
Why?
|
Urea Cycle Disorders, Inborn | 3 | 2025 | 84 | 0.430 |
Why?
|
Colon | 3 | 2021 | 380 | 0.380 |
Why?
|
Graft Rejection | 3 | 2024 | 624 | 0.370 |
Why?
|
Intestinal Mucosa | 5 | 2021 | 813 | 0.360 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2022 | 325 | 0.310 |
Why?
|
Trichosporonosis | 2 | 2018 | 8 | 0.290 |
Why?
|
Enterocytes | 2 | 2021 | 75 | 0.280 |
Why?
|
Liver Cirrhosis | 3 | 2025 | 934 | 0.280 |
Why?
|
Biopsy | 6 | 2025 | 1302 | 0.260 |
Why?
|
Pilomatrixoma | 2 | 2015 | 5 | 0.230 |
Why?
|
Trinitrobenzenesulfonic Acid | 2 | 2021 | 24 | 0.220 |
Why?
|
Interleukin-15 | 1 | 2025 | 96 | 0.220 |
Why?
|
Child | 19 | 2025 | 25711 | 0.210 |
Why?
|
Elasticity Imaging Techniques | 2 | 2022 | 140 | 0.210 |
Why?
|
Gastritis | 2 | 2019 | 373 | 0.210 |
Why?
|
Fatty Liver | 1 | 2025 | 210 | 0.210 |
Why?
|
Intestines | 3 | 2021 | 613 | 0.200 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2021 | 129 | 0.200 |
Why?
|
Goblet Cells | 2 | 2021 | 107 | 0.200 |
Why?
|
Alagille Syndrome | 1 | 2022 | 49 | 0.190 |
Why?
|
Enterocolitis | 1 | 2022 | 28 | 0.190 |
Why?
|
Mutation | 4 | 2018 | 6260 | 0.190 |
Why?
|
Pleural Effusion | 1 | 2022 | 109 | 0.190 |
Why?
|
Exanthema | 1 | 2022 | 71 | 0.190 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2021 | 48 | 0.180 |
Why?
|
Phytosterols | 1 | 2021 | 29 | 0.180 |
Why?
|
Amyloidosis | 1 | 2022 | 71 | 0.180 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 2653 | 0.180 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2021 | 45 | 0.180 |
Why?
|
Herpesvirus 6, Human | 1 | 2021 | 55 | 0.180 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 808 | 0.180 |
Why?
|
Bacteroides | 1 | 2021 | 37 | 0.170 |
Why?
|
Humans | 41 | 2025 | 133540 | 0.170 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 41 | 0.170 |
Why?
|
Dipeptides | 1 | 2021 | 62 | 0.170 |
Why?
|
Ileum | 1 | 2021 | 136 | 0.170 |
Why?
|
Lymphangioma | 1 | 2020 | 25 | 0.170 |
Why?
|
Bifidobacterium | 1 | 2021 | 70 | 0.170 |
Why?
|
Lymphatic Vessels | 1 | 2020 | 37 | 0.170 |
Why?
|
Inflammation | 4 | 2021 | 1598 | 0.170 |
Why?
|
Liver Glycogen | 1 | 2020 | 23 | 0.170 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 228 | 0.170 |
Why?
|
Interleukins | 1 | 2021 | 132 | 0.170 |
Why?
|
Mice | 14 | 2022 | 18808 | 0.160 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 238 | 0.160 |
Why?
|
Adolescent | 13 | 2025 | 20514 | 0.160 |
Why?
|
Neuroblastoma | 1 | 2025 | 539 | 0.160 |
Why?
|
Myocarditis | 1 | 2021 | 137 | 0.160 |
Why?
|
Infant | 11 | 2024 | 13122 | 0.160 |
Why?
|
Child, Preschool | 10 | 2025 | 14762 | 0.160 |
Why?
|
Immunocompromised Host | 2 | 2018 | 304 | 0.160 |
Why?
|
Granuloma, Giant Cell | 1 | 2019 | 13 | 0.160 |
Why?
|
Animals | 18 | 2023 | 36266 | 0.160 |
Why?
|
Gastrointestinal Microbiome | 4 | 2021 | 822 | 0.150 |
Why?
|
Infliximab | 1 | 2019 | 68 | 0.150 |
Why?
|
Intestine, Small | 1 | 2021 | 317 | 0.150 |
Why?
|
Bile Acids and Salts | 1 | 2021 | 257 | 0.150 |
Why?
|
Mononuclear Phagocyte System | 1 | 2018 | 9 | 0.150 |
Why?
|
CX3C Chemokine Receptor 1 | 1 | 2018 | 13 | 0.150 |
Why?
|
Invasive Fungal Infections | 1 | 2018 | 18 | 0.150 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2018 | 9 | 0.150 |
Why?
|
Dacryocystitis | 1 | 2018 | 22 | 0.150 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 54 | 0.150 |
Why?
|
Fat Emulsions, Intravenous | 2 | 2021 | 79 | 0.150 |
Why?
|
Nonsense Mediated mRNA Decay | 1 | 2018 | 33 | 0.150 |
Why?
|
Trichosporon | 1 | 2017 | 5 | 0.140 |
Why?
|
Opportunistic Infections | 1 | 2018 | 79 | 0.140 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 392 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 1 | 2025 | 871 | 0.140 |
Why?
|
Fungemia | 1 | 2017 | 22 | 0.140 |
Why?
|
Probiotics | 1 | 2021 | 229 | 0.140 |
Why?
|
Streptococcus gallolyticus subspecies gallolyticus | 1 | 2017 | 2 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2021 | 448 | 0.140 |
Why?
|
Denys-Drash Syndrome | 1 | 2017 | 5 | 0.140 |
Why?
|
Granuloma | 1 | 2018 | 70 | 0.140 |
Why?
|
WT1 Proteins | 1 | 2017 | 27 | 0.140 |
Why?
|
Th1 Cells | 1 | 2018 | 159 | 0.140 |
Why?
|
Female | 24 | 2025 | 71524 | 0.140 |
Why?
|
Symbiosis | 1 | 2018 | 102 | 0.140 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2023 | 425 | 0.140 |
Why?
|
Male | 22 | 2025 | 65774 | 0.140 |
Why?
|
Molecular Chaperones | 1 | 2018 | 176 | 0.140 |
Why?
|
Parenteral Nutrition | 2 | 2021 | 199 | 0.140 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2017 | 36 | 0.140 |
Why?
|
Filamins | 1 | 2017 | 27 | 0.140 |
Why?
|
Genetic Diseases, Inborn | 1 | 2021 | 453 | 0.130 |
Why?
|
Diet Therapy | 1 | 2017 | 43 | 0.130 |
Why?
|
Copper | 1 | 2017 | 69 | 0.130 |
Why?
|
Bronchogenic Cyst | 1 | 2016 | 8 | 0.130 |
Why?
|
Sjogren's Syndrome | 1 | 2018 | 97 | 0.130 |
Why?
|
Lacrimal Apparatus | 1 | 2018 | 128 | 0.130 |
Why?
|
Esophagogastric Junction | 1 | 2016 | 36 | 0.130 |
Why?
|
Bilirubin | 1 | 2017 | 131 | 0.130 |
Why?
|
Esophageal Diseases | 1 | 2016 | 37 | 0.130 |
Why?
|
Esophageal Achalasia | 1 | 2016 | 44 | 0.130 |
Why?
|
Fundoplication | 1 | 2016 | 71 | 0.130 |
Why?
|
Glucocorticoids | 1 | 2019 | 408 | 0.130 |
Why?
|
Eosinophilic Esophagitis | 1 | 2017 | 81 | 0.130 |
Why?
|
Telomerase | 3 | 2001 | 179 | 0.130 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 247 | 0.130 |
Why?
|
Branchial Region | 1 | 2015 | 9 | 0.130 |
Why?
|
Pharyngeal Muscles | 1 | 2015 | 11 | 0.120 |
Why?
|
Oropharynx | 1 | 2015 | 39 | 0.120 |
Why?
|
Pharyngeal Diseases | 1 | 2015 | 20 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2017 | 138 | 0.120 |
Why?
|
Spermatocele | 1 | 2015 | 2 | 0.120 |
Why?
|
Thoracic Wall | 1 | 2015 | 40 | 0.120 |
Why?
|
Polyps | 1 | 2015 | 44 | 0.120 |
Why?
|
Infant, Newborn | 6 | 2021 | 8571 | 0.120 |
Why?
|
Blister | 1 | 2015 | 22 | 0.120 |
Why?
|
Scrotum | 1 | 2015 | 28 | 0.120 |
Why?
|
Biological Therapy | 1 | 2015 | 25 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 584 | 0.120 |
Why?
|
Ultrasonography | 2 | 2021 | 993 | 0.120 |
Why?
|
Streptococcal Infections | 1 | 2017 | 248 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 239 | 0.110 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2019 | 555 | 0.110 |
Why?
|
Iron | 1 | 2017 | 302 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2015 | 127 | 0.110 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 135 | 0.110 |
Why?
|
Swine Diseases | 1 | 2014 | 42 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 118 | 0.110 |
Why?
|
Hair Diseases | 1 | 2013 | 14 | 0.110 |
Why?
|
Mast Cells | 1 | 2013 | 83 | 0.100 |
Why?
|
Enteritis | 1 | 2013 | 55 | 0.100 |
Why?
|
Lung Diseases | 1 | 2017 | 399 | 0.100 |
Why?
|
Sarcoma | 1 | 2015 | 201 | 0.100 |
Why?
|
Kidney | 1 | 2020 | 1404 | 0.100 |
Why?
|
Cornea | 1 | 2018 | 681 | 0.100 |
Why?
|
Lung Transplantation | 1 | 2017 | 334 | 0.100 |
Why?
|
Microbiota | 2 | 2015 | 444 | 0.100 |
Why?
|
Eosinophils | 1 | 2013 | 128 | 0.100 |
Why?
|
Testis | 1 | 2015 | 426 | 0.100 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 149 | 0.100 |
Why?
|
Eosinophilia | 1 | 2013 | 106 | 0.100 |
Why?
|
Cell Differentiation | 2 | 2021 | 2023 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 472 | 0.100 |
Why?
|
T-Lymphocytes | 1 | 2021 | 1804 | 0.100 |
Why?
|
Skin | 1 | 2015 | 551 | 0.090 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2013 | 90 | 0.090 |
Why?
|
Graft Survival | 2 | 2024 | 557 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 1967 | 0.090 |
Why?
|
Carcinogenesis | 1 | 2014 | 363 | 0.090 |
Why?
|
Ceramides | 2 | 2001 | 47 | 0.090 |
Why?
|
Feces | 1 | 2015 | 785 | 0.090 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2014 | 248 | 0.090 |
Why?
|
Laparoscopy | 1 | 2016 | 513 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2022 | 4742 | 0.090 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 650 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 3471 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 382 | 0.090 |
Why?
|
Argininosuccinic Aciduria | 2 | 2025 | 55 | 0.090 |
Why?
|
Stem Cells | 1 | 2015 | 749 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 773 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 360 | 0.080 |
Why?
|
DNA | 1 | 2014 | 1665 | 0.070 |
Why?
|
DNA Methylation | 1 | 2015 | 1145 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2024 | 690 | 0.070 |
Why?
|
Interleukin-10 | 2 | 2021 | 191 | 0.070 |
Why?
|
Voriconazole | 2 | 2018 | 35 | 0.070 |
Why?
|
Soybean Oil | 2 | 2021 | 71 | 0.070 |
Why?
|
Chronic Disease | 2 | 2024 | 1250 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 1848 | 0.070 |
Why?
|
Biomarkers | 3 | 2022 | 3412 | 0.070 |
Why?
|
Fish Oils | 2 | 2021 | 85 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2021 | 506 | 0.060 |
Why?
|
Immunity, Mucosal | 2 | 2018 | 92 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2024 | 17436 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2013 | 906 | 0.060 |
Why?
|
Antifungal Agents | 2 | 2018 | 309 | 0.060 |
Why?
|
Incidence | 2 | 2024 | 3386 | 0.060 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2025 | 66 | 0.060 |
Why?
|
Cytokines | 2 | 2021 | 1395 | 0.060 |
Why?
|
Swine | 2 | 2021 | 1215 | 0.060 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 1413 | 0.060 |
Why?
|
Gangliosides | 1 | 2025 | 72 | 0.060 |
Why?
|
Natural Killer T-Cells | 1 | 2025 | 84 | 0.050 |
Why?
|
CpG Islands | 2 | 2015 | 346 | 0.050 |
Why?
|
Diet, Western | 1 | 2023 | 18 | 0.050 |
Why?
|
Allografts | 1 | 2024 | 196 | 0.050 |
Why?
|
Endoglin | 1 | 2022 | 22 | 0.050 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 21 | 0.050 |
Why?
|
Primates | 1 | 2023 | 87 | 0.050 |
Why?
|
Prednisone | 1 | 2022 | 290 | 0.050 |
Why?
|
Cough | 1 | 2022 | 96 | 0.050 |
Why?
|
Amoxicillin | 1 | 2022 | 124 | 0.050 |
Why?
|
Chest Pain | 1 | 2022 | 133 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2022 | 220 | 0.050 |
Why?
|
Dyspnea | 1 | 2022 | 160 | 0.050 |
Why?
|
Ileitis | 1 | 2021 | 10 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 158 | 0.050 |
Why?
|
Emulsions | 1 | 2021 | 71 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 2021 | 51 | 0.040 |
Why?
|
Cell Line | 2 | 2018 | 2833 | 0.040 |
Why?
|
Mucin-2 | 1 | 2021 | 42 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2022 | 271 | 0.040 |
Why?
|
Fibrosis | 1 | 2023 | 464 | 0.040 |
Why?
|
Hyperammonemia | 1 | 2021 | 63 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 4786 | 0.040 |
Why?
|
Phenotype | 2 | 2023 | 4523 | 0.040 |
Why?
|
Transfection | 3 | 2014 | 1085 | 0.040 |
Why?
|
Lymphatic System | 1 | 2020 | 21 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 83 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 406 | 0.040 |
Why?
|
Serotonin | 1 | 2021 | 223 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2014 | 1045 | 0.040 |
Why?
|
Ethanol | 1 | 2021 | 171 | 0.040 |
Why?
|
Antioxidants | 1 | 2023 | 373 | 0.040 |
Why?
|
Observer Variation | 1 | 2020 | 312 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 13001 | 0.040 |
Why?
|
Metabolism, Inborn Errors | 1 | 2021 | 121 | 0.040 |
Why?
|
DNA, Viral | 1 | 2021 | 498 | 0.040 |
Why?
|
Cysts | 1 | 2020 | 108 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 162 | 0.040 |
Why?
|
Antibodies | 1 | 2001 | 382 | 0.040 |
Why?
|
Longevity | 1 | 2021 | 158 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2019 | 34 | 0.040 |
Why?
|
Pyloric Antrum | 1 | 2019 | 62 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 324 | 0.040 |
Why?
|
Young Adult | 2 | 2025 | 9899 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 67 | 0.040 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 253 | 0.040 |
Why?
|
Lipopeptides | 1 | 2018 | 36 | 0.040 |
Why?
|
RAW 264.7 Cells | 1 | 2018 | 44 | 0.040 |
Why?
|
Remission Induction | 1 | 2019 | 308 | 0.040 |
Why?
|
Echinocandins | 1 | 2018 | 44 | 0.040 |
Why?
|
Amphotericin B | 1 | 2018 | 93 | 0.040 |
Why?
|
Germ-Free Life | 1 | 2018 | 65 | 0.040 |
Why?
|
Prevalence | 1 | 2025 | 2654 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2018 | 117 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 1079 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2018 | 64 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2018 | 3956 | 0.040 |
Why?
|
Febrile Neutropenia | 1 | 2017 | 15 | 0.040 |
Why?
|
Permeability | 1 | 2018 | 132 | 0.040 |
Why?
|
Bacterial Adhesion | 1 | 2018 | 104 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2018 | 118 | 0.040 |
Why?
|
Crohn Disease | 1 | 2021 | 287 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2018 | 122 | 0.040 |
Why?
|
Interferon Type I | 1 | 2018 | 114 | 0.040 |
Why?
|
Gene Deletion | 1 | 2021 | 809 | 0.040 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2018 | 106 | 0.030 |
Why?
|
Drug Eruptions | 1 | 2017 | 32 | 0.030 |
Why?
|
Colectomy | 1 | 2018 | 81 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2018 | 157 | 0.030 |
Why?
|
RNA | 1 | 2001 | 600 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2019 | 244 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 342 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2017 | 99 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2018 | 199 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2018 | 269 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2001 | 1065 | 0.030 |
Why?
|
Neutropenia | 1 | 2018 | 199 | 0.030 |
Why?
|
Middle Aged | 3 | 2025 | 29347 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 1130 | 0.030 |
Why?
|
Lung Neoplasms | 3 | 2001 | 1793 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 156 | 0.030 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2018 | 214 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1323 | 0.030 |
Why?
|
DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 26 | 0.030 |
Why?
|
beta Catenin | 1 | 2017 | 225 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2018 | 537 | 0.030 |
Why?
|
Heterozygote | 1 | 2018 | 716 | 0.030 |
Why?
|
Animals, Suckling | 1 | 2015 | 51 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2001 | 1753 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1486 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2018 | 2895 | 0.030 |
Why?
|
Back | 1 | 2015 | 11 | 0.030 |
Why?
|
Exons | 1 | 2018 | 833 | 0.030 |
Why?
|
Syndrome | 1 | 2018 | 1148 | 0.030 |
Why?
|
Tumor Cells, Cultured | 3 | 2001 | 1098 | 0.030 |
Why?
|
Vomiting | 1 | 2015 | 110 | 0.030 |
Why?
|
Family | 1 | 2018 | 589 | 0.030 |
Why?
|
Epithelium | 1 | 2015 | 370 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 1200 | 0.030 |
Why?
|
Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
Olive Oil | 1 | 2014 | 24 | 0.030 |
Why?
|
Neutrophil Infiltration | 1 | 2014 | 66 | 0.030 |
Why?
|
gamma-Glutamyltransferase | 1 | 2014 | 48 | 0.030 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2014 | 35 | 0.030 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 160 | 0.030 |
Why?
|
Laryngoscopy | 1 | 2015 | 157 | 0.030 |
Why?
|
Homeostasis | 1 | 2018 | 748 | 0.030 |
Why?
|
Plant Oils | 1 | 2014 | 37 | 0.030 |
Why?
|
Airway Obstruction | 1 | 2015 | 168 | 0.030 |
Why?
|
Base Sequence | 1 | 2018 | 3168 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2020 | 3063 | 0.030 |
Why?
|
Cell Count | 1 | 2013 | 255 | 0.030 |
Why?
|
Infant Formula | 1 | 2014 | 100 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 82 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 693 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2014 | 262 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2013 | 220 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 567 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 536 | 0.020 |
Why?
|
Adult | 2 | 2025 | 31933 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2014 | 453 | 0.020 |
Why?
|
Endoscopy | 1 | 2013 | 291 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2013 | 633 | 0.020 |
Why?
|
Gene Dosage | 1 | 2013 | 456 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 613 | 0.020 |
Why?
|
Disease Progression | 1 | 2017 | 2236 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2013 | 501 | 0.020 |
Why?
|
Cell Movement | 1 | 2014 | 916 | 0.020 |
Why?
|
Lipids | 1 | 2014 | 567 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2013 | 1124 | 0.020 |
Why?
|
Risk Factors | 1 | 2024 | 11056 | 0.020 |
Why?
|
Premature Birth | 1 | 2014 | 416 | 0.020 |
Why?
|
Gene Expression | 1 | 2014 | 1612 | 0.020 |
Why?
|
Time Factors | 2 | 2014 | 6579 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 2783 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2014 | 3161 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 3968 | 0.020 |
Why?
|
Rats | 1 | 2014 | 3876 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 3839 | 0.020 |
Why?
|
Apoptosis | 1 | 2014 | 1929 | 0.020 |
Why?
|
Prospective Studies | 1 | 2017 | 6654 | 0.020 |
Why?
|
Signal Transduction | 1 | 2017 | 4879 | 0.010 |
Why?
|
DNA-Binding Proteins | 2 | 2001 | 2159 | 0.010 |
Why?
|
Cycloheximide | 1 | 2001 | 46 | 0.010 |
Why?
|
Ubiquitins | 1 | 2001 | 44 | 0.010 |
Why?
|
Glucosylceramides | 1 | 2001 | 3 | 0.010 |
Why?
|
Daunorubicin | 1 | 2001 | 27 | 0.010 |
Why?
|
Resting Phase, Cell Cycle | 1 | 2001 | 18 | 0.010 |
Why?
|
Cholic Acids | 1 | 2001 | 16 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 160 | 0.010 |
Why?
|
Genes, myc | 1 | 2001 | 107 | 0.010 |
Why?
|
Luciferases | 1 | 2001 | 137 | 0.010 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2001 | 43 | 0.010 |
Why?
|
Phosphatidylserines | 1 | 2001 | 50 | 0.010 |
Why?
|
G1 Phase | 1 | 2001 | 67 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2001 | 64 | 0.010 |
Why?
|
Glucosyltransferases | 1 | 2001 | 52 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 7509 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2001 | 394 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2001 | 258 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2001 | 216 | 0.010 |
Why?
|
Cell Membrane | 1 | 2001 | 485 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 835 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 1731 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2001 | 2111 | 0.010 |
Why?
|